Good afternoon ladies and gentlemen, all the ASPIRE (Asia Pacific Initiative on Reproduction) board member, country representatives, member of ASPIRE and all of delegates.
Now it's the time for us in Asia Pacific to lead assisted reproductive technology in the world since we have the highest number of population, number of countries, number of scientist, which is also enriched with valuable culture and tradition in our region. Within 12 years of development, ASPIRE has been growing so fast and very promising, presented many distinctive and excellent activities to increase the quality of ART services in Asia Pacific. Several outstanding achievements of ASPIRE including performing annual ASPIRE scientific meeting, ASPIRE master class and participate actively in many ASPIRE member country national fertility meeting.
Being realize that many challenges and opportunities, currently ASPIRE empowering our organization body through assignment of the new two vice president and establish special interest group committee to accommodate every development and advancement in reproductive endocrinology and infertility areas. We also propose "ASPIRE", as our new core value: Aiming the goals, Strategic thinking, Powerful program, Inspiring, Recognizable, Empowering.
Thank you very much to The Immediate Past President Chii Ruey Tzeng and all the previously former President, PC Wong, SY Moon, Yoshiharu Morimoto, Robert Norman and Jaideep Malhotra and founder of ASPIRE, Bruno Lunenfeld, who have already working very hard and successfully putting the basic fundamental of ASPIRE as a young organization in the world of assisted reproductive technology.
In the next 2 years our main goal is bridging the gap of ART in Asia Pacific by empowering our region. Three main aspect which very important are competencies, access to and quality of ART services. ASPIRE master class will improve the level of competencies of clinician, embryologist, nurse or IVF counselor. ASPIRE Campus / Chapter will leverage engagement of ASPIRE with every member among the countries in Asia Pacific. To increase the number of publication, our own ASPIRE official journal is currently under establishment. On the other hand, ASPIRE effort to build public awareness in ART is a must.
We also really keen to establish standard minimum of practice guidelines in ART and reproductive endocrinology as well as our intention to participate actively in ART registry for Asia Pacific region under coordination of ICMART therefore ASPIRE registry system must be well developed.
Last but not least, as our bench marking organization I'd like to thanks also to ASRM and ESHRE who have already become our good friends and partners in developing ASPIRE as a professional organization.
Let us empowering our region to bridge the gap of ART in Asia Pacific.
President of ASPIRE